MediWound Ltd. (MDWD) P/E Ratio History
Historical price-to-earnings valuation from 2019 to 2020
Loading P/E history...
MDWD Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 9, 2026, MediWound Ltd. (MDWD) trades at a price-to-earnings ratio of -7.9x, with a stock price of $16.57 and trailing twelve-month earnings per share of $-1.86.
The current P/E is 194% below its 5-year average of 8.4x. Over the past five years, MDWD's P/E has ranged from a low of 4.6x to a high of 16.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 21.9x, MDWD trades at a 136% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
Relative to the broader market, MDWD trades at a notable discount to the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MDWD DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MDWD P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $449M | 5.2Lowest | - | +146%Best | |
| $8B | 25.0 | 1.09Best | -25% | |
| $109B | 34.0 | 2.29 | +8% | |
| $80B | 27.8 | - | +55% | |
| $17B | 30.5 | - | -25% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
MDWD Historical P/E Data (2019–2020)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2020 Q1 | $10.99 | $1.72 | 6.4x | -23% | |
| FY2019 Q4 | $21.70 | $1.29 | 16.9x | +102% | |
| FY2019 Q3 | Mon Sep 30 2019 00:00:00 GM | $22.40 | $4.91 | 4.6x | -45% |
| FY2019 Q2 | Sun Jun 30 2019 00:00:00 GM | $23.66 | $4.20 | 5.6x | -33% |
Average P/E for displayed period: 8.4x
See MDWD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MDWD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MDWD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMDWD — Frequently Asked Questions
Quick answers to the most common questions about buying MDWD stock.
Is MDWD stock overvalued or undervalued?
MDWD trades at -7.9x P/E, below its 5-year average of 8.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does MDWD's valuation compare to peers?
MediWound Ltd. P/E of -7.9x compares to sector median of 21.9x. The discount suggests lower growth expectations or higher risk.
What is MDWD's PEG ratio?
MDWD PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2019-2020.